6 completed. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 3 | 1 | Completed 1 |
Follow Glutens: new trials by email Literature Review of Glutens trials Research Report on Glutens
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission Ritlecitinib, Placebo, Gluten - Celiac Disease | Phase 2 | Completed | Massachusetts General Hospital | 62 | 2023-03-01 | 2026-10-30 |
| Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet Placebo, TAK-101, Gluten - Celiac Disease | Phase 2 | Completed | Takeda | 102 | 2022-06-23 | 2026-10-06 |
| Effect of Addition of Short Course of Prednisolone to Gluten Free Diet in Naive Celiac Disease Patients Prednisolone and Gluten free diet, Gluten free diet - Celiac Disease | Phase 2 / Phase 3 | Completed | All India Institute of Medical Sciences | 33 | 2009-04-01 | 2012-01-19 |
| Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease Larazotide acetate, Placebo, Gluten 900 mg - Celiac Disease | Phase 2 | Completed | 9 Meters Biopharma, Inc. | 42 | 2009-04-01 | 2017-09-20 |
| Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease larazotide acetate, placebo, 900 mg gluten - Celiac Disease | Phase 2 | Completed | 9 Meters Biopharma, Inc. | 171 | 2007-08-01 | 2017-09-20 |
| ScanBrit Dietary Intervention in Autism Gluten- and casein-free diet - Autism, Autism Spectrum Disorder (ASD) | Phase 2 | Completed | Center for Autisme, Denmark | 72 | 2006-04-01 | 2010-10-01 |
Celiac Disease (5) · Attention Deficit Disorder with Hyperactivity (1) · Autism Spectrum Disorder (1) · Autistic Disorder (1)
9 Meters Biopharma, Inc. (2) · All India Institute of Medical Sciences (1) · Center for Autisme, Denmark (1) · Massachusetts General Hospital (1) · Takeda (1)
United States (4) · Canada (3) · Australia (1) · India (1) · New Zealand (1)
Francisco Leon, MD, Ph.D. (1) · Francisco Leon, MD, PhD (1) · Govind Makharia, MD, DM (1) · Maureen Leonard, MD (1)